Myelo Therapeutics Gmbh Is A Biotechnology Company Based In Berlingermanyfounded In March 2016The Company Specializes In Medical Countermeasures And Cancer Supportive Care Therapiesfocusing On Unmet Medical Needs Related To Radiation Exposure And Complications From Chemotherapymyelo Therapeutics Operates As A Subsidiary Of Pentixapharm Ag And Became Fully Owned By Eckert Und Ziegler Strahlenund Medizintechnik Ag In 2023 The Company Develops Therapies To Address Acute Radiation Syndrome And Radiation Induced Myelosuppressionit Also Works On Reducing Chemotherapy Induced Myelosuppression Through Its Lead Compoundmyelo001Which Is An Orally Administered Small Molecule Targeting Hematopoiesismyelo Therapeutics Collaborates With Various Organizationsincluding The Us National Institute Of Health And The European Commissionae S European Defence Fundto Advance Its Research And Innovationsthe Company Aims To Improve Patient Outcomes In Oncology Treatments And Enhance Radiation Protection Through Its Scientific Efforts
No conferences found for this company.
| Company Name | Myelo Therapeutics Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
